E2F4 and acute myeloid leukemia: The over-expression of E2F4 in our HRMS subgroup was also consistent with a recent report that E2F4 over-expression was associated with poor prognosis in AML patients, and that in a mouse model, depleting E2F4 inhibited proliferation and suppressed the growth of AML cells (Feng et al., 2020).